Pfizer and BioNTech Announce an Agreement with U.S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2 Read more
Daiichi Sankyo and Gustave Roussy Enter Innovative Research Collaboration for DXd ADCs DS-1062 and Patritumab Deruxtecan Read more
Roche collaborates with Blueprint Medicines to bring a new treatment to people with RET-altered cancers Read more
TREMFYA Approved by FDA as the First Selective Interleukin (IL)-23 Inhibitor for Active Psoriatic Arthritis Read more
Kymera and Sanofi Enter into Strategic Partnership to Advance Novel Protein Degrader Therapies to Patients Read more
Moderna and ROVI Announce Collaboration for OUS Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate Read more
Pfizer Pledges $100 Million to New Industry Fund to Help Fight Growing Threat of Antimicrobial Resistance Read more